Parkside Financial Bank & Trust’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
PAI
6CM
Parkside Financial Bank & Trust's ANAB Position: Q1 2026 in Review
Parkside Financial Bank & Trust held its AnaptysBio (ANAB) position steady in Q1 2026 at 25 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.
Parkside Financial Bank & Trust first reported a position in ANAB in Q2 2025 and has held it in 4 quarters since. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Parkside Financial Bank & Trust held 25 shares of AnaptysBio worth $1.39K as of Q1 2026.
- Parkside Financial Bank & Trust left its AnaptysBio share count unchanged in Q1 2026.
- AnaptysBio made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2235 holding.
- Parkside Financial Bank & Trust first reported a position in AnaptysBio in Q2 2025 and has held it in 4 quarters since.
- 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.